CureBay Raises USD 21 Mn Series B to Scale Rural Healthcare Delivery
The Series B round was led by Bertelsmann India Investments, with continued support from existing investors Elevar Equity and British International Investment.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
CureBay, a hybrid healthcare platform focused on rural India, has raised USD 21 million in a Series B funding round led by Bertelsmann India Investments. The round also saw participation from existing investors Elevar Equity and British International Investment.
The capital will be deployed to strengthen CureBay's proprietary tech stack and fuel its expansion into new states such as Jharkhand, Bihar, Uttar Pradesh, and Madhya Pradesh. The company plans to invest in AI-driven platform upgrades, rural-first workflow automation tools, and proprietary algorithms that support predictive healthcare and operational efficiency.
"We are focused on addressing healthcare access challenges in underserved regions," said Priyadarshi Mohapatra, Founder and CEO of CureBay. "The funding will support the next phase of our scale-up, including technology development, team building, and operational expansion."
Founded in 2021 by Priyadarshi Mohapatra, Shobhan Mohapatra, and Sanjay Swain, CureBay was created to bridge the healthcare gap in rural India, where doctor access is limited, and hospital visits often lead to income loss and exploitation by healthcare brokers.
"They get lured into clinics that promise quick treatment, pay money, and often get subpar care. That's the reason they avoid traveling for care," Mohapatra explained.
To address this, CureBay provides concierge-style support for rural patients referred to tertiary hospitals. A dedicated assistant accompanies them—like a trusted family doctor—ensuring they receive the right treatment without confusion or exploitation.
CureBay's hybrid model combines tech-enabled eClinics with a digital infrastructure that offers doctor consultations, diagnostics, pharmacy delivery, and referrals—all under one platform. Its unique "circle" clinic network is supported by integrated logistics, local diagnostics, and medical partnerships.
"While most rural solutions remain fragmented, CureBay uniquely delivers the full continuum of care under one platform," said Pankaj Makkar, Managing Director, Bertelsmann India Investments. "This investment reflects our commitment to mission-driven companies transforming Bharat."
CureBay operates over 150 eClinics across Odisha and Chhattisgarh, delivering affordable and accessible healthcare to rural households. Its preventive care program has 90,000 active members with a renewal rate exceeding 60%. The company reported that its Balasore and Puri circles have achieved operational profitability, showcasing the viability of its rural-first healthcare model.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNN
4 hours ago
- CNN
Why men with broken heart syndrome are more likely to die than women
Heart disease Chronic diseasesFacebookTweetLink Follow Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being. A 59-year-old man arrived at the Peking University First Hospital in Beijing for a procedure when he started having severe chest pain and shortness of breath. Four months earlier, he had cancerous tumors removed from his bladder. Around his family, he tried his best to appear strong and avoided discussions of his health. Privately, his severe anxiety over the possibility of a cancer recurrence kept him awake at night. Doctors said the man was experiencing takotsubo cardiomyopathy — also known as broken heart syndrome, as documented in a 2021 case study. The rare stress-induced heart condition has been observed primarily in women, but a study published in the Journal of the American Heart Association in May found that the illness may be more deadly for the men who get it. Thought to be caused by extreme emotional or physical events — such as learning about the death of a loved one, winning the lottery or lifting a heavy sofa — takotsubo cardiomyopathy, or TC, occurs when the heart muscle is flooded with stress hormones, causing part of it to 'freeze' in place. As the heart struggles to properly pump blood, symptoms resemble those of a heart attack, including chest pain, heart palpitations and irregular heartbeat. The new study analyzed data from nearly 200,000 patients hospitalized for TC in the United States between 2016 and 2020. While women accounted for 83% of the cases, men were more than twice as likely to die from the condition — with a mortality rate of 11.2%. 'The differences between men and women are a very striking finding,' said study coauthor Dr. Mohammad Reza Movahed, a clinical professor of medicine at the University of Arizona in Tucson. 'It raises a new, interesting question that should really be studied.' Similar to differences between men's and women's cardiovascular health more generally, the discrepancies in TC death rates are not well understood, Movahed said, especially because they counter trends in other heart diseases. It's widely theorized, however, that differences in hormone levels play a role. Stressful situations trigger the adrenal glands to release our fight-or-flight hormones, called catecholamines. They are meant to increase our blood pressure and raise our heart rate, but extreme levels can temporarily 'stun' cells in the heart's tissue, leading to TC, Movahed explained. Men are thought to produce more catecholamines during stressful situations compared with women, possibly leading men to present with more severe cases of TC, he suggested. Estrogen, a sex hormone produced at higher levels in women, may also have a protective effect on the cardiovascular system, making it easier to manage an extreme influx of catecholamines and reducing the risk of severe complications from TC, said Dr. Louis Vincent, a noninvasive-cardiology research fellow at the University of Miami, who coauthored a similar, multiyear study investigating discrepancies in men and women who had TC. Vincent was not involved in the new study. Beyond biological differences, social factors may play a role as well. 'Most (physicians) know about takotsubo, but they may think of it as a disease just affecting women, so the diagnosis might be overlooked in men,' said Dr. Deepak Bhatt, a cardiologist and the director of Mount Sinai Fuster Heart Hospital who was not involved in the study. 'With misdiagnosis, care is delayed, and that can sometimes lead to worse outcomes.' Men may also seek care at a later stage of illness, believing that their symptoms are manageable or may pass, said Dr. Alejandro Lemor, an assistant professor of interventional cardiology at the University of Mississippi Medical Center who was also not involved in the study. Deadly complications from TC include blood clots, stroke, cardiac arrest and heart failure, Lemor said. If the condition is caught early, medications can reduce the risk of having these complications, restore proper heart function and allow for full recovery within weeks, he added. Movahed's team was able to factor for important variables like age, race, income, chronic lung disease, hypertension and diabetes in the findings. However, there was no patient data on other comorbid diseases, such as a history of stroke or the presence of a Covid-19 infection, Vincent said. Additionally, the new study included in-patient diagnostic data only for those hospitalized with TC, so those who received outpatient care or died later from complications outside the hospital were likely not counted in the analysis, Movahed noted. To establish a firmer explanation for the differences in mortality rates between men and women and further test treatment methods, a more detailed dataset would be needed, Vincent said. 'People should be aware in studies like this, we're presenting findings that are based on diagnostic codes, and we're not looking at patient procedures or lab results,' Vincent said. 'But it's powerful in the sense that it lets us look at large populations and look at trends. And I think that this trend of a higher mortality in men is worth taking a deeper look into.' Sudden, severe chest pain or shortness of breath should always be treated as a medical emergency, warned Bhatt, who is also a professor of cardiovascular medicine at the Icahn School of Medicine at Mount Sinai in New York City. 'It's not a time to tough it out at home or get on the internet to figure it out. … Don't try to track down your primary care provider. Call emergency services,' Bhatt said. 'Time matters. By winning those few hours, you could save yourself irreparable damage to your heart.' Symptoms following physical stressors — a common cause of TC in men — should not be ignored, Movahed said, especially preceding medical events such as asthma attacks, seizures or complications from drug use. And while TC is caused by sudden stress, Bhatt said that managing chronic stress with daily meditation or exercise can lead to better cardiovascular health overall while giving you routines to fall back on in unexpected situations.
Washington Post
4 hours ago
- Washington Post
Will you be able to get a COVID-19 shot? Here's what we know so far
Want a COVID-19 vaccination this fall? For many Americans, it's not clear how easy it will be to get one — and some doctors already see signs of trouble. Health Secretary Robert F. Kennedy Jr., who was a longtime anti-vaccine activist, said last month that the shots are no longer recommended for healthy children and pregnant women, usurping a decision normally made by scientific experts, not political appointees . Days later, the Centers for Disease Control and Prevention said healthy children and pregnant women 'may' get COVID-19 vaccinations, removing stronger language that those groups 'should' get the shots. Its website currently lists no advice for pregnant women — graying out that section of the vaccine guidance chart. The change follows an earlier Trump administration step to limit COVID-19 vaccinations among healthy people under age 65. Until now, the U.S. — following guidance from independent experts who advise the CDC — has recommended yearly COVID-19 vaccinations for everyone age 6 months and older. Together, the moves have left health experts, vaccine makers and insurers uncertain about what to advise and what comes next. In Seattle, University of Washington infectious disease expert Dr. John B. Lynch said he recently advised a fellow health care worker who's pregnant to get vaccinated. She agreed, only to be turned away by two pharmacies. 'That's the practical implication,' Lynch told reporters in an Infectious Diseases Society of America briefing. 'We see confusion play out. We see chaos play out. And we see barriers to access.' The conflicting statements are also leaving primary care doctors uncertain of how to advise patients, Lynch added. 'I'm not sure when that confusion is going to be abated,' he said. Some of this season's vaccine is still available. Insurance industry experts say if people had coverage before Kennedy's announcement, insurance likely would still pay for the shots. In a move that could help access, Wisconsin's health department announced that state 'continues to recommend the current COVID-19 vaccine during pregnancy and for every person 6 months and older,' and reiterating the its state Medicaid program will continue to cover it. Who will be able to get what vaccines this fall is still unclear. Vaccine manufacturers plan to issue updated COVID-19 shots in the late summer or fall. But the Food and Drug Administration has said it plans to limit approval of seasonal shots to seniors and others at high risk, pending more studies of everyone else. Even if the U.S. approves vaccines only for certain groups, it still may be possible for others to get the shot depending on the outcome of upcoming advisory meetings, regulatory moves and decisions from insurers and employers. Insurers base coverage decisions on the recommendations of that CDC panel, the Advisory Committee on Immunization Practices. It's not clear what role that panel now will play. Paying out of pocket could cost about $200. The CDC says its new language for healthy kids — known as shared decision-making — means health insurers must pay for the vaccinations. Some insurers and employers may decide to still cover the shots no matter what, said Jen Kates, a senior vice president at the non-profit KFF, which studies health care issues. She noted that they may view the expense as worthwhile if it avoids a higher bill from someone hospitalized by the coronavirus. The FDA published a list of health conditions it said would qualify, including asthma, cancer, diabetes, obesity and physical inactivity. The CDC has a more extensive list. But, again, it isn't yet known how this will play out. For example, it could be hard for people to prove they're qualified. If they're vaccinated at a drugstore, for instance, the pharmacist wouldn't normally know about underlying health problems or even ask. And Ajay Sethi, an epidemiologist at the University of Wisconsin-Madison, said 'this elephant in the room' is that blocking vaccination to the healthy may mean people who have a risk factor and simply don't know it will miss out. Adding to the confusion was Kennedy's implication that the coronavirus isn't dangerous to pregnant women. COVID-19 complications during pregnancy can include preterm birth as well as serious illness in the mother, and the Society for Maternal-Fetal Medicine said it 'strongly reaffirms' its recommendation for vaccination during pregnancy. Moreover, vaccinating mom can provide spillover protection for the newborn for a few months, until he or she is old enough for their own vaccination, Lynch stressed. ___ Associated Press writer Mike Stobbe contributed to this report. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Yahoo
6 hours ago
- Yahoo
Millions more to get test results via NHS app, government says
The NHS app will become the default method of communication for millions more patients in England and save the health service £200m over the next three years, the government has said. More test results, screening invitations and appointment reminders will be sent directly to smartphones as part of a £50m investment in the app, in a move away from traditional communication methods such as letters. It is estimated that at least 50 million letters are sent to patients each year. The Department of Health and Social Care said that people who cannot access app messaging - including elderly patients - will receive text messages and then a letter as a last resort, and NHS phone lines would be freed up. The department says 270 million messages will be sent through the NHS app this financial year - an increase of 70 million on the previous year. Push notifications will provide appointment reminders to patients to try to reduce the risk of no attendance - with around eight million missed appointments in elective care missed in 2023/24. Work is also under way to enable users of the app to add appointments to their phone calendars and request help from their local GP surgeries. Figures show that more than 11 million people in the UK log into the NHS app every month, while almost 20 million are opted in to receive healthcare messages from the app. It is hoped the changes will give patients better access to manage their healthcare journey and make informed decisions about their care. NHS app services, which were launched in December 2018, are now used in 87% of hospitals across England. Health Secretary Wes Streeting said further investment in the app would bring the NHS into the digital age so that being a patient was as "convenient as online banking or ordering a takeaway". He added that moving away from paper communication could free up funding for front line services. Rachel Power, chief executive of the Patient's Association, said the upgrade was a "significant step in modernising how patients receive information". The British Medical Association (BMA) has previously warned that a reliance on apps to the NHS to communicate with patients risked alienating patients who don't have access to digital technology. It followed the government's announcement in January that it planned to allow more patients in England to book treatments and appointments through the app. Last month, NHS England announced millions of patients would be able to get "Amazon-style" tracking updates on their prescriptions through the app, to check if their medicines are ready to collect or have been despatched for delivery. New app trial cuts skin cancer referrals by 50% NHS App upgrade to give patients more choice over treatment Patients to get full access to record on NHS App
